Inflammatory oedema induced by the Lys-49 phospholipase A2 homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide

Biochemical Pharmacology

Volumn 59, Issue 10, 2000, Pages 1289-1294

  Landucci, Elen C T ^a   De Castro, Rogerio C ^a   Toyama, Marcos ^a   Giglio, Jose R ^b   Marangoni, Sergio ^a   De Nucci, Gilberto ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Mast cell; p bromophenacyl bromide; Phospholipases A2; Proteoglycans; Vascular permeability

Indexed keywords

4 BROMOPHENACYL BROMIDE; APAFANT; DERMATAN SULFATE; HEPARIN; ICATIBANT; MEPYRAMINE; PHOSPHOLIPASE A2; SNAKE VENOM; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CONTROLLED STUDY; EDEMA; MALE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PAW EDEMA; PERITONEUM MAST CELL; PRIORITY JOURNAL; RABBIT; RAT; SEROTONIN RELEASE; SKIN EDEMA;

ANIMALS; CELL DEGRANULATION; CROTALID VENOMS; EDEMA; INFLAMMATION MEDIATORS; MALE; MAST CELLS; PHOSPHOLIPASES A; RABBITS; RATS; RATS, WISTAR;

EID: 0034658218     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00248-3     Document Type: Article

References (40)

1. 2. J Biol Chem. 269:1994;13057-13060.
2. 2 myotoxins from Bothrops snake venoms. Toxicon. 33:1995;1405-1424.
3. Osaka A. Hemorrhagic, necrotizing and edema-forming effects of snake venoms. Lee C.Y. Handbook of Experimental Pharmacology. 1989;480-546 Springer, New York.
4. 2-induced oedema in rat paw. Eur J Pharmacol. 166:1989;505-510.
5. 2-induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action. Agents Actions. 36:1992;258-263.
6. 2 myotoxins A highly conserved class of proteins . Toxicon. 34:1996;1237-1242.
7. Melo P.A., Homsi-Brandeburgo M.I., Giglio J.R., Suarez-Kurtz G. Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions. Toxicon. 31:1993;285-291.
8. 2 from Bothrops asper venom by glycosaminoglycans of the heparin/heparan sulfate family. Biochem Pharmacol. 47:1994;1509-1518.
9. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J Biol Chem. 269:1994;29867-29873.
10. 2. J Immunol. 151:1993;5675-5684.
11. 2 generation in mouse bone marrow-derived mast cells. J Biol Chem. 271:1996;25936-25944.
12. Homsi-Brandeburgo M.I., Queiroz L.S., Santo-Neto H., Rodrigues-Simioni L., Giglio J.R. Fractionation of Bothrops jararacussu snake venom Partial chemical characterization and biological activity of bothropstoxin . Toxicon. 26:1988;615-627.
13. 2 homologues Dissociation between enzymatic and biological activities . Eur J Pharmacol. 343:1998;257-263.
14. Mancuso L.C., Correa M.M., Vieira C.A., Cunha O.A.B., Lachat J.J., Selistre de Araujo H.S.A., Ownby C.L., Giglio J.R. Fractionation of Bothrops pirajai snake venom Isolation and characterization of piratoxin-I, a new myotoxic protein . Toxicon. 33:1995;615-626.
15. Toyama M.H., Mancuso L.C., Giglio J.R., Novello J.C., Oliveira B., Marangoni S. A quick procedure for the isolation of dimeric piratoxins-I and II, two myotoxins from Bothrops pirajai snake venom. N-terminal sequencing. Biochem Mol Biol Int. 37:1995;1047-1055.
16. Brain S.D., Williams T.J. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol. 86:1985;855-860.
17. Coleman J.W., Holgate S.T., Church M.K., Godfrey R. Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Biochem J. 198:1981;615-619.
18. 2. Toxicon. 27:1989;613-635.
19. 2 in Clinical Inflammation: Molecular Approaches to Pathophysiology (Eds. Glaser KB and Vadas P), Vol. 5, pp. 93-124. CRC Press, New York, 1995.
20. 2 purified from porcine pancreas and snake venoms. Toxicon. 31:1993;949-956.
21. 2 isolated from Bothrops asper and Bothrops godmani snake venoms Effects on enzymatic and pharmacological properties . Toxicon. 35:1997;241-252.
22. 2 to phospholipid micelles Importance of the amino-terminus . Biochemistry. 30:1991;9090-9097.
23. 2 by heparin. Eur J Biochem. 221:1994;481-490.
24. 2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J Biol Chem. 271:1996;30041-30051.
25. Ennis M., Pearce F.L., Weston P.M. Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol. 70:1980;329-334.
26. Antunes E., Mariano M., Cirino G., Levi S., de Nucci G. Pharmacological characterization of polycation-induced rat hind-paw oedema. Br J Pharmacol. 101:1990;986-990.
27. Fredens K., Dahl R., Venge P. In vitro studies of the interaction between heparin and eosinophil cationic protein. Allergy. 46:1991;27-29.
28. Santana A., Hyslop S., Antunes E., Mariano M., Bakhle Y.S., de Nucci G. Inflammatory responses induced by poly-L-arginine in rat lungs in vivo. Agents Actions. 39:1993;104-110.
29. Marcondes S., Grassi-Kassissi D.M., Hyslop S., de Nucci G. Modulation of polycation-induced human platelet aggregation. Thromb Haemorrh Dis. 7:1993;47-50.
30. Donato J.L., Marcondes S., Antunes E., Nogueira M.D., Nader H.B., Dietrich C.P., Rendu F., de Nucci G. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation. Br J Pharmacol. 119:1996;1447-1453.
31. 2. Biochemistry. 13:1974;1446-1454.
32. 2, affects its pharmacological activities. Toxicon. 31:1993;1202-1206.
33. 2 covalently inhibited by p-bromo-phenacyl-bromide. J Mol Biol. 200:1988;181-188.
34. 2 modified by p-bromo-phenacyl-bromide. Toxicon. 36:1998;875-886.
35. Kyger E.M., Franson R.C. Nonspecific inhibition of enzymes by p-bromophenacyl bromide. Inhibition of human platelet phospholipase C and modification of sulfhydryl groups. Biochim Biophys Acta. 794:1984;96-103.
36. Nader H.B., Dietrich C.P. Natural occurrence and possible biological role of heparin. Lane D.A., Lindahl U. Heparin Chemical and Biological Properties, Clinical Applications . 1989;81-96 Edward Arnold, London.
37. Needham L., Hellewell P.G., Williams T.J., Gordon J.L. Endothelial functional responses and increased vascular permeability induced by polycations. Lab Invest. 59:1988;538-548.
38. 2. J Biol Chem. 269:1994;1575-1578.
39. 2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem. 270:1995;8963-8970.
40. 2. Trends Pharmacol Sci. 20:1999;162-170.